{
  "meta": {
    "identifier": "IMELDA",
    "pubmed": "25273343",
    "registration": "NCT00929240",
    "publication_date": "2014-09-28 00:00:00",
    "arms": 2,
    "disease": "breast_cancer",
    "subjects": 185,
    "weibull_by_arm": {
      "bevacizumab": {
        "scale": 33.35383954238565,
        "shape": 1.2234032385478497
      },
      "bevacizumab_capecitabine": {
        "scale": 47.32250737809721,
        "shape": 1.6796206364922583
      }
    },
    "weibull_max_diff": 0.6497379659377023,
    "time_scale": "Months",
    "title": "A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer",
    "condition_list": [
      "Breast Cancer"
    ],
    "data_index": null
  },
  "arms": [
    {
      "events": [
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      "time": [
        1.18,
        1.61,
        1.72,
        2.13,
        2.77,
        3.58,
        4.38,
        5.77,
        6.06,
        6.18,
        6.41,
        6.95,
        7.29,
        7.36,
        7.38,
        7.81,
        8.01,
        8.2,
        8.25,
        8.73,
        9.61,
        9.66,
        11.2,
        11.3,
        11.3,
        12.1,
        12.2,
        12.3,
        12.5,
        15.2,
        16.4,
        16.5,
        17.8,
        17.8,
        17.9,
        18.5,
        18.7,
        18.8,
        19.5,
        21.8,
        22.4,
        22.5,
        22.8,
        23.3,
        23.7,
        26.1,
        28.4,
        28.7,
        29.6,
        29.9,
        31.8,
        32.2,
        32.6,
        4.015,
        4.995,
        6.995,
        8.0,
        10.45,
        13.4,
        16.45,
        22.45,
        24.45,
        24.85,
        25.2,
        25.75,
        26.15,
        26.5,
        27.25,
        27.5,
        27.9,
        28.15,
        28.45,
        28.75,
        29.05,
        29.35,
        29.65,
        30.45,
        30.85,
        31.25,
        31.7,
        32.05,
        32.55,
        33.35,
        33.75,
        34.15,
        34.45,
        34.85,
        35.25,
        35.65,
        36.95,
        37.95,
        39.95,
        40.95,
        42.55
      ],
      "arm_name": "bevacizumab"
    },
    {
      "events": [
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        1,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0,
        0
      ],
      "time": [
        1.21,
        5.95,
        5.95,
        8.71,
        9.71,
        10.3,
        10.6,
        11.8,
        13.2,
        13.3,
        15.4,
        16.0,
        16.2,
        16.5,
        16.6,
        17.3,
        18.2,
        19.4,
        19.6,
        19.7,
        21.2,
        21.9,
        22.0,
        22.5,
        23.9,
        25.9,
        27.7,
        29.3,
        32.0,
        32.3,
        32.6,
        36.4,
        39.0,
        0.7385,
        1.49,
        2.245,
        4.505,
        6.535,
        7.025,
        7.545,
        8.04,
        8.59,
        10.05,
        11.05,
        22.45,
        24.45,
        24.85,
        25.55,
        25.55,
        26.15,
        26.55,
        27.25,
        27.55,
        27.85,
        28.15,
        28.45,
        28.75,
        29.05,
        29.35,
        29.65,
        30.25,
        30.45,
        30.65,
        30.95,
        31.15,
        31.35,
        31.65,
        31.9,
        32.05,
        32.35,
        32.5,
        32.75,
        33.25,
        33.45,
        33.75,
        33.95,
        34.25,
        34.45,
        34.75,
        34.95,
        35.25,
        35.45,
        35.75,
        36.45,
        36.95,
        37.45,
        37.95,
        38.45,
        39.65,
        40.25,
        40.95
      ],
      "arm_name": "bevacizumab_capecitabine"
    }
  ]
}